Valneva SE (VALN) Exchange Rate Effect (2021 - 2026)
Valneva SE's (VALN) quarterly Exchange Rate Effect came in at $400395.0 in Q1 2026, up 164.52% year-on-year from $151368.8 in Q1 2025, and up 6.82% quarter-over-quarter from $374822.0 in Q4 2025.
Valneva SE (VALN) Exchange Rate Effect (2021 - 2026) Analysis & Trends
Valneva SE has disclosed Exchange Rate Effect across 6 years of filings, most recently posting $400395.0 for Q1 2026.
- Exchange Rate Effect for Q1 2026 came in at $400395.0, up 164.52% year-over-year; the trailing twelve-month figure through Mar 2026 was -$2.8 million (down 276.12% YoY), and the FY2025 annual result was -$4.0 million, down 304.33% from the prior year.
- Exchange Rate Effect came in at $400395.0 for Q1 2026 at Valneva SE, up from $374822.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $633.2 million in Q3 2023 to a low of -$633.4 million in Q2 2023.
- The 5-year median for Exchange Rate Effect is -$49100.3 (2025), against an average of -$160233.8.
- Peak annual rise in Exchange Rate Effect reached 58979.99% in 2023, while the deepest fall reached 69281.37% in 2023.
- Valneva SE's Exchange Rate Effect stood at -$2.7 million in 2022, then soared by 104.43% to $119429.3 in 2023, then soared by 1969.56% to $2.5 million in 2024, then plunged by 84.84% to $374822.0 in 2025, then increased by 6.82% to $400395.0 in 2026.
- The last three Exchange Rate Effect figures came in at $400395.0 (Q1 2026), $374822.0 (Q4 2025), and -$49100.3 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FX Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | 3.60 Mn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | -2.70 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | -40.30 Mn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | 8.68 Mn |
| 10 | Valneva SE | 167.33 Mn | 44.10 Mn | 5.08 Mn | 400,395.01 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 400,395.01 |
| Mar 31, 2026 | 400,395.01 |
| Dec 31, 2025 | 374,822.01 |
| Dec 31, 2025 | 374,822.01 |
| Sep 30, 2025 | -49,100.31 |
| Sep 30, 2025 | -49,100.31 |
| Jun 30, 2025 | -3.49 Mn |
| Jun 30, 2025 | -3.49 Mn |
| Mar 31, 2025 | -620,611.82 |
| Mar 31, 2025 | -620,611.82 |
| Dec 31, 2024 | 2.47 Mn |
| Dec 31, 2024 | 2.47 Mn |
| Sep 30, 2024 | -1.18 Mn |
| Sep 30, 2024 | -1.18 Mn |
| Jun 30, 2024 | 903,508.68 |
| Jun 30, 2024 | 903,508.68 |
| Mar 31, 2024 | -286,799.51 |
| Mar 31, 2024 | -286,799.51 |
| Dec 31, 2023 | 119,429.33 |
| Dec 31, 2023 | 119,429.33 |